Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
This growth is being propelled by the landmark SELECT trial results confirming cardiovascular risk reduction benefits of Wegovy in obese non-diabetic patients, which catalyzed new reimbursement coverage including Medicare coverage in the United States estimated to add 3.4 million newly eligible patients
A psychiatrist writing about this recently made a comparison that stopped me in my tracks: he likened GLP-1 medications to the early days of SSRIs in the 1990s
As a dual GIP/GLP-1 receptor agonist, tirzepatide works through additional pathways compared to pure GLP-1 agonists
Obesity and overweight, with or without metabolic dysregulation, pose vexing problems for many patients with mood, anxiety, or psychotic disorders
A Therapeutic Use Exemption allows an athlete to use a banned substance if its medically necessary
It has been explored for its potential to support longevity and regulate key biological processes linked to aging
